PERKENI n Malang XI · pada kelainan dibidang endokrin. Title: Ann MEU XI First.cdr Author:...
Transcript of PERKENI n Malang XI · pada kelainan dibidang endokrin. Title: Ann MEU XI First.cdr Author:...
PERKUMPULANENDOKRINOLOGII N D O N E S I A
P E RK EN IP E R K EN IP E R K EN I
XIMalangEndocrinology Update Hotel Atria Malang
12 - 14 April 2019
Sekretariat: Divisi Endokrin Metabolik dan Diabetes, Departemen Ilmu Penyakit Dalam FK UB/ RSUD dr. Saiful Anwar,
Telp : 0341-351 445Jl. J.A. Suprapto 2 Malang E-mail : [email protected] | CP: Emerita 081233656805
Uang tidak kembali bila registrasi dibatalkann
Sertifikat hanya diberikan kepada peserta yang hadirn
............................................. , 2019
( .................................................. )
Pembayaran Tunai Transfer Bank Mandiri Capem RSCM NO. REK. 122-00-0760795-8 A/N PB PERKENI
n
Mohon diisi dan di email ke [email protected]
n Biaya Pendaftaran
Sampai dengan 20 Maret 2019
Setelah 20 Maret 2019Workshop
Simposium Internist
GP
Medical Student
Rp. 1.500.000,-
Rp. 1.000.000,-
Rp. 500.000,-
Rp. 1.000.000,-
Rp. 750.000,-
Rp. 300.000,-
Simposium + WorkshopSimposium + 1 Workshop GP Rp. 2.250.000,-
Rp. 2.750.000,-
Rp. 1.500.000,-
Rp. 1.750.000,-Simposium + 1 Workshop Internist
Rp. 1.500.000,-
Rp. 1.500.000,-
Rp. 1.000.000,-
Rp. 1.000.000,-
Clinical Workshop 1: Emergency in Endocrine diseases
Clinical Workshop 2:Diabetes in special cases
Simposium:Workshop:
Plenary Lecture:n Clinical decision making in endocrinologyn What is the guideline tell and not to tell us :
Summary of new ADA/EASD 2018 perspectiven Data mining to improve diabetes outcome :
Malang Diabetes Registry Projectn Clnicial inertia : Barrier to diabetes
management in primary care
n Perioperative management in Endocrine diseases
n Diabetes in special cases
n Screening tests for common endocrine diseasesn Pitfalls in Endocrine Testing and interpretation:
When What You See is not What You've Gotn Glucose-lowering therapies in older patients :
How to minimising the riskn Pharmacogenetic of type 2 diabetes :
Implication for clinical practicen Cardiovascular impact of glucose lowering
drugsn Diabetic Kidney Disease : What You need to
know ?n Newer Insulin in diabetes management : Do we
need it ?n Diabetes and Foot : What the recent guideline
sayn Exercise and type 2 diabetes : From metabolic
insight to clinical implicationn Choosing Evidence-Based Therapy for Type 2
Diabetes Mellitus with Cardiovascular Diseasen Insulin and cancer revisited : An endocrinologist
perspectiven Preventing Cardiovascular disease in diabetes :
Focus on Lipid and Blood Pressure
Pameran
Meet the Expert &Drug Positioning
Endo-diabetes 4.0 :Redefinisi “treat to target”pada kelainan dibidang endokrin